AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gluwin MV 2mg/500mg/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ambrosia Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Gluwin MV 2mg/500mg/0.3mg Tablet SR

Diabetic patients using Gluwin MV 2mg/500mg/0.3mg SR tablets, an anti-diabetic medication, should adhere to their prescribed dosage and timing. This combination drug manages blood glucose in adult type 2 diabetes. Consistent daily intake, ideally with meals, maximizes effectiveness. Dosage adjustments, determined by your physician based on blood sugar monitoring, may occur. Discontinuing Gluwin MV without medical consultation risks elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management, as guided by your doctor. Hypoglycemia (low blood sugar), manifested by sweating, dizziness, headache, and tremors, is a common side effect. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are crucial preventative measures. Alcohol consumption should be limited due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. Gluwin MV is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Consult your doctor before using this medicine during pregnancy or breastfeeding. Regular blood glucose monitoring, along with blood cell and liver function tests as advised by your physician, is essential.

Primary Ingredients of Gluwin MV 2mg/500mg/0.3mg Tablet SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Gluwin MV 2mg/500mg/0.3mg Tablet SR

Managing type 2 diabetes

Major Benefits of Gluwin MV 2mg/500mg/0.3mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for Gluwin MV 2mg/500mg/0.3mg Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Gluwin MV 2mg/500mg/0.3mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Gluwin MV 2mg/500mg/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Gluwin MV 2mg/500mg/0.3mg Tablet SR. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.

How Gluwin MV 2mg/500mg/0.3mg Tablet SR works:

Extended-release Gluwin MV tablets (2mg/500mg/0.3mg) contain a triple combination of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gluwin MV 2mg/500mg/0.3mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Gluwin MV 2mg/500mg/0.3mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Gluwin MV tablets (2mg/500mg/0.3mg) are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The extended-release Gluwin MV 2mg/500mg/0.3mg tablet is likely unsafe for individuals with kidney impairment and its use should be avoided. Medical advice is necessary. Furthermore, its use is contraindicated in patients experiencing severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Gluwin MV 2mg/500mg/0.3mg SR tablets cautiously, potentially requiring dose modification. Consult a physician. Low initial doses are generally recommended for individuals with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Gluwin MV 2mg/500mg/0.3mg Tablet SR :

Should you forget to take a Gluwin MV 2mg/500mg/0.3mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Gluwin MV 2mg/500mg/0.3mg Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Gluwin MV 2mg/500mg/0.3mg Tablet SR

Gluwin MV 2mg/500mg/0.3mg Extended-Release tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus in adults, enhancing glycemic control when combined with a healthy diet and exercise regimen. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and improves insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar spikes. This formulation is unsuitable for type 1 diabetes.
Patients taking Gluwin MV 2mg/500mg/0.3mg Tablet SR may experience typical adverse reactions including hypoglycemia, nausea, diarrhea, taste disturbances, flatulence, abdominal pain, headache, skin eruptions, and respiratory infections.
Patients with hypersensitivity to Gluwin MV 2mg/500mg/0.3mg Tablet SR constituents or inactive ingredients should not take this medication. Its use is contraindicated in individuals with moderate to severe nephropathy, inflammatory bowel disorders, colonic ulcers, and metabolic acidosis, including diabetic ketoacidosis.
Combining Gluwin MV 2mg/500mg/0.3mg SR tablets and alcohol is unsafe. This combination can reduce blood sugar to dangerously low levels (hypoglycemia) and heighten the risk of lactic acidosis.
Indeed, Gluwin MV 2mg/500mg/0.3mg SR tablets may induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medicine. Ensure it remains inaccessible to children, animals, and others.
Gluwin MV 2mg/500mg/0.3mg...
80
MRP 98
18% off